Skip to main content
. 2017 Sep 29;7:12456. doi: 10.1038/s41598-017-12334-2

Figure 3.

Figure 3

FE65 T579 phosphorylation potentiates FE65-mediated APP processing. (A) HEK293 cells were co-transfected with GAL4-APP, pFR-Luc and phRL-TK together with EV, FE65, FE65 T579A or FE65 T579E. Phosphomimetic mutation of FE65 T579 further enhances the effect of FE65 on APP-GAL4 cleavage. n = 5. *P < 0.001. Results are means ± S.D. The expression of FE65 and the mutants were determined by immunoblotting. (B) Cells were transfected with APP + BACE1 + FE65/T579A/T579E. Transfected cell lysates were resolved on 16% Tris-Tricine gel, and immunoblotted for APP CTFs. Arrows denote CTF-α, -β or -β’. UT: untransfected. Two exposures of CTF blot were shown (C) Cells were transfected with APP together with EV, FE65, FE65 T579A or FE65 T579E. Levels of secreted Aβ1–40 (top graph) and 1–42 (bottom graph) were measured by corresponding Aβ ELISA kits. FE65 T579E phosphomimetic mutation potentiates FE65-mediated Aβ liberation. n = 5. *P < 0.001. Results are means ± S.D.